Furthermore, the CIS myoblasts exhibited impaired myotube differentiation ability and decreased expressions of MyoD1, myogenin, and MHC as well as a decreased ratio of p-AKT1 (ser473)/AKT1 compared to the NOR myoblasts. The gene discussed is HLA-C; the disease is in situ carcinoma.